The Japanese Patent Office is granting another patent to Episurf Medical, titled "Method and Mode for Manufacturing a Surgical Kit for Cartilage Repair."Â
Lipogems received FDA 510(k) clearance to market a Microfragmented Adipose Tissue Transplant system for use in orthopaedic and arthroscopic procedures.Â
By the end of 2Q18, Episurf Medical will file for its Investigational Device Exemption with FDA to initiate a U.S. study of the Episealer® knee implant.